AI MARKET SCANNING

Immix Biopharma Inc

AVG HISTORICAL GAP -1.00%
MAX GAP RECORD -8.75%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IMMX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 07, 2026 Earnings Release 2026-08-07 (AFTER CLOSE)
+0.36%
Mar 25, 2026 Earnings Release 2026-03-25 (AFTER CLOSE)
-8.75%
Nov 07, 2025 Earnings Release 2025-11-07 (AFTER CLOSE)
+3.49%
Aug 08, 2025 Earnings Release 2025-08-08 (AFTER CLOSE)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-3.30%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
-1.74%
Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE)
+0.00%
Mar 28, 2024 Earnings Release 2024-03-28 (AFTER CLOSE)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.6%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IMMX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗